The drug, developed in partnership with AbbVie Inc, was approved for patients with acute myeloid leukemia (AML) aged 75 or older, or those ineligible for intensive induction chemotherapy.
Original source: https://health.economictimes.indiatimes.com/news/pharma/roche-abbvie-cancer-drug-gets-accelerated-fda-approval/66743733?utm_source=RSS&utm_medium=ETRSS
